Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
Aditi S. Khatpe, Adedeji K. Adebayo, Christopher Herodotou, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 369-369
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
Yao Tian, Zhaohui Chen, Peng Wu, et al.
Advanced Science (2023) Vol. 10, Iss. 12
Open Access | Times Cited: 38
Breast Cancer MCF-7 Cell Spheroid Culture for Drug Discovery and Development
Guangping Chen, William Liu, Bingfang Yan
Journal of Cancer Therapy (2022) Vol. 13, Iss. 03, pp. 117-130
Open Access | Times Cited: 27
Female-specific dysfunction of sensory neocortical circuits in a mouse model of autism mediated by mGluR5 and estrogen receptor α
Gemma Molinaro, Jacob E. Bowles, Katilynne Croom, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114056-114056
Open Access | Times Cited: 5
Challenges and Prospects in HER2-Positive Breast Cancer-Targeted Therapy
Xi‐Yin Li, Xueying Zhang, Saige Yin, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 207, pp. 104624-104624
Open Access
The current landscape of aromatase inhibitors for the treatment of estrogen receptor-positive breast carcinoma
Khushboo Bhutani, S. K. Vishwakarma, Priyanka Yadav, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2025) Vol. 250, pp. 106729-106729
Closed Access
Estrogen-sensitive activation of SGK1 induces M2 macrophages with anti-inflammatory properties and a Th2 response at the maternal–fetal interface
Yiyun Lou, Zhujing Fu, Ye Tian, et al.
Reproductive Biology and Endocrinology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
Maxwell R. Lloyd, Komal Jhaveri, Kevin Kalinsky, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 10, pp. 743-761
Closed Access | Times Cited: 4
Sex Differences in Colon Cancer: Genomic and Nongenomic Signalling of Oestrogen
Brian J. Harvey, Harry Harvey
Genes (2023) Vol. 14, Iss. 12, pp. 2225-2225
Open Access | Times Cited: 11
Antioxidant Effects and Potential Molecular Mechanism of Action of Diplocyclos palmatus (L.) C. Jeffrey Fruits Based on Systematic Network Pharmacology with Experimental Validation
Mitesh Patel, Lamya Ahmed Al‐Keridis, Sarah Owdah Alomrani, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138638-138638
Closed Access | Times Cited: 3
Synergistic effects of T-2 toxin and selenium deficiency exacerbate renal fibrosis through modulation of the ERα/PI3K/Akt signaling pathway
Haobiao Liu, Xue Lin, Mumba Mulutula Chilufya, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 269, pp. 115748-115748
Open Access | Times Cited: 8
What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland
Ina Pretzell, Alexander Desuki, Annalen Bleckmann, et al.
Oncology Research and Treatment (2024) Vol. 47, Iss. 9, pp. 410-419
Closed Access | Times Cited: 2
Crosstalk of methylation and tamoxifen in breast cancer (Review)
Jin Shen, Yan He, Shengpeng Li, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 2
Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway
Yuhong Li, Shuying Hu, Yueqi Chen, et al.
Phytomedicine (2023) Vol. 118, pp. 154924-154924
Closed Access | Times Cited: 7
Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma
Juliana María Motta, Hebatallah Hassan, Sherif Ibrahim
Cancers (2023) Vol. 15, Iss. 6, pp. 1794-1794
Open Access | Times Cited: 6
The association between migraine and breast cancer risk: A systematic review and meta-analysis
Elahe Hesari, Mozhgan Ahmadinezhad, Maedeh Arshadi, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263628-e0263628
Open Access | Times Cited: 10
Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition
Soad L. Kabil, Hayam E. Rashed, Noura Mostafa Mohamed, et al.
Life Sciences (2023) Vol. 331, pp. 122037-122037
Closed Access | Times Cited: 5
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
Lorenzo Gerratana, Andrew A. Davis, Marko Velimirovic, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 5
ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?
Margaux Betz, Vincent Massard, Pauline Gilson, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5169-5169
Open Access | Times Cited: 5
Irreversible inhibition of estrogen receptor α signaling and the emergence of hormonal resistance in MCF7 breast cancer cells induced by DNA damage agents
Alexander M. Scherbakov, Danila V. Sorokin, Valeria Razuvaeva, et al.
Biomedical Reports (2024) Vol. 20, Iss. 3
Open Access | Times Cited: 1
MicroRNA signature of stromal-epithelial interactions in prostate and breast cancers
Ankit Roy Choudhury, A Nagesh, Surabhi Gupta, et al.
Experimental Cell Research (2024) Vol. 441, Iss. 2, pp. 114171-114171
Closed Access | Times Cited: 1
Impact of HDAC6-mediated progesterone receptor expression on the response of breast cancer cells to hormonal therapy
Wafaa S. Ramadan, Rahma K. Alseksek, Soraya Mouffak, et al.
European Journal of Pharmacology (2024), pp. 177001-177001
Closed Access | Times Cited: 1
Extract of Curculigo capitulata Ameliorates Postmenopausal Osteoporosis by Promoting Osteoblast Proliferation and Differentiation
Ying Wang, Xueru Wang, Kai‐Jin Wang, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 2028-2028
Open Access | Times Cited: 1
Suppressing the PI3K/AKT Pathway by miR-30d-5p Mimic Sensitizes Ovarian Cancer Cells to Cell Death Induced by High-Dose Estrogen
Alexandra Varga, Éva Márton, Arnold Markovics, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2060-2060
Open Access | Times Cited: 8
Ovariectomy induces hyperalgesia accompanied by upregulated estrogen receptor α and protein kinase B in the rat spinal cord
Lihong Li, Dandan Ling, Hong Lin, et al.
Physiology & Behavior (2023) Vol. 271, pp. 114342-114342
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top